Jennifer Michaelson, Chief Development Officer: Cullinan Therapeutics CGEM Sell · Filed 23/04/20

Trade details

Type: Insider sale
Amount: $2,548.98
Shares · price: 238 sh · $10.71 a share
Held after: 90,879 sh
Stock: Cullinan Therapeutics CGEM
Person: Jennifer MichaelsonChief Development Officer
Trade date: 23/04/18
Filed: 23/04/20
Days to filing: 2 days

Sold 0.3% of holdings

Share of holding sold: 0.3%

Cullinan Therapeutics trades, last 26 weeks

What else happened in Cullinan Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/19~23/05/18

Jennifer Michaelson's recent trades

Jennifer MichaelsonChief Scientific Officer
Planned sale10b5-1 planCullinan Therapeutics
Planned sale10b5-1 plan
Cullinan Therapeutics
CGEM
$176.7K
8,000 sh
$176.7K
Filed 09/08
Traded 09/08
Jennifer MichaelsonChief Scientific Officer
Planned sale10b5-1 planCullinan Therapeutics
Planned sale10b5-1 plan
Cullinan Therapeutics
CGEM
$588K
30,000 sh
$588K
Filed 08/13
Traded 08/13
Jennifer MichaelsonChief Scientific Officer
Planned sale10b5-1 planCullinan Therapeutics
Planned sale10b5-1 plan
Cullinan Therapeutics
CGEM
$141K
8,000 sh
$141K
Filed 07/06
Traded 07/06
Jennifer MichaelsonChief Scientific Officer
Sell10b5-1 planCullinan Therapeutics
Sell10b5-1 plan
Cullinan Therapeutics
CGEM
$113.9K
7,800 sh
$113.9K
Filed 05/06
Traded 05/05
Jennifer MichaelsonChief Scientific Officer
Sell10b5-1 planCullinan Therapeutics
Sell10b5-1 plan
Cullinan Therapeutics
CGEM
$3,116
200 sh
$3,116
Filed 05/06
Traded 05/05

Jennifer Michaelson, Chief Officer — sold $2,549 of Cullinan Therapeutics CGEM · 0.3% of holdings | Whalegun